Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs CPAY✓SelectedUSD · CPAYGSK vs CPAY performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs CPAY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
CPAY return
+88.4%
Excess return
-47.2%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioCPAYExcessAlpha
1D-0.1%-1.0%+0.9%0.0%
7D-5.3%-7.0%+1.7%-4.4%
30D-3.7%+5.5%-9.1%-4.4%
3M-7.3%+4.3%-11.6%-7.9%
6M-4.2%+22.6%-26.9%-7.1%
YTD+0.9%+42.8%-42.0%-4.7%
1Y+7.3%+55.0%-47.7%+0.3%
3Y+52.7%+82.7%-29.9%+36.6%
All+41.1%+88.4%-47.2%+23.4%

Cumulative growth

Daily Returns

Daily percentage return beside CPAY.

Daily Out/Under-Performance

Portfolio return minus CPAY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CPAY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded CPAY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling